Gene: GLYR1
Official Full Name: glyoxylate reductase 1 homologprovided by HGNC
Gene Summary: Enables several functions, including chromatin-protein adaptor activity; methylated histone binding activity; and nucleosome binding activity. Involved in transcription elongation-coupled chromatin remodeling and transcription initiation-coupled chromatin remodeling. Located in cytosol and nucleoplasm. Part of nucleosome. Is active in chromatin. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO05248 | GLYR1 Knockout cell line (HeLa) | Human | GLYR1 | 1:3~1:6 | Negative | Online Inquiry |
KO05249 | GLYR1 Knockout cell line (HCT 116) | Human | GLYR1 | 1:2~1:4 | Negative | Online Inquiry |
KO05250 | GLYR1 Knockout cell line (HEK293) | Human | GLYR1 | 1:3~1:6 | Negative | Online Inquiry |
KO05251 | GLYR1 Knockout cell line (A549) | Human | GLYR1 | 1:3~1:4 | Negative | Online Inquiry |
GLYR1 Gene Knockout Cell Lines represent a powerful tool in molecular biology, specifically designed to elucidate the role of the GLYR1 gene in various physiological and pathological processes. These engineered cell lines are produced by utilizing CRISPR-Cas9 technology to create a specific knockout of the GLYR1 gene, allowing researchers to investigate the gene's contributions to cellular function without its influence.
The primary mechanism of action involves the targeted disruption of the gene, leading to the absence of the GLYR1 protein. This absence can significantly alter various cellular pathways, including energy metabolism, stress response, and cellular signaling pathways. As such, these knockout cell lines serve as invaluable models for dissecting the gene’s biological function and understanding its implications in diseases like cancer and metabolic disorders.
In terms of scientific importance, GLYR1 Gene Knockout Cell Lines are crucial in both research and clinical settings. They provide insight into the gene’s potential role as a biomarker for disease progression or treatment response, and can support drug discovery initiatives aimed at targeting related pathways. Furthermore, by facilitating a more profound exploration of GLYR1's function, these cell lines can accelerate translational research efforts that might lead to novel therapeutic options.
Compared to traditional cell lines, the specific knockout of the GLYR1 gene allows for more precise investigations, minimizing confounding factors by eliminating variable gene expression. This specificity affords researchers greater control over experimental conditions, enabling more reproducible and reliable results.
For researchers and clinicians looking to gain deeper insights into the GLYR1 gene, these knockout cell lines offer a pragmatic choice for experimental design, laying the groundwork for innovative research. Leveraging years of expertise in the field of molecular biology and genetic engineering, our company is dedicated to providing high-quality biological products that empower scientific discovery and foster advancements in healthcare.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.